Are we measuring what we intend to measure? Implications for the management of healthcare-acquired infections

M. Aldeyab; M. Scott; G. Conlon-Bingham; A. Nagar; D. Farren; M. Kearney

doi:10.1016/j.jhin.2015.10.016

Are we measuring what we intend to measure? Implications for the management of healthcare-acquired infections

M. Aldeyab, M. Scott, G. Conlon-Bingham, A. Nagar, D. Farren, M. Kearney

Dept of Mgmt, Leadership & Marketing

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	206-208
Number of pages	3
Journal	Journal of Hospital Infection
Volume	92
Issue number	2
Early online date	9 Nov 2015
DOIs	https://doi.org/10.1016/j.jhin.2015.10.016
Publication status	E-pub ahead of print - 9 Nov 2015

Bibliographical note

Export Date: 15 September 2018

CODEN: JHIND

Correspondence Address: Aldeyab, M.; Pharmacy and Medicines Management Centre, Antrim Area Hospital, Northern Health and Social Care Trust, Beech House, United Kingdom; email: Mamoon.Aldeyab@northerntrust.hscni.net

References: Aldeyab, M.A., McElnay, J.C., Scott, M.G., A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking (2014) J Antimicrob Chemother, 69, pp. 1132-1141; Peterson, J.C., Paget, S.A., Lachs, M.S., The risk of comorbidity (2012) Ann Rheum Dis, 71, pp. 635-637; Conlon-Bingham, G., Aldeyab, M.A., Kearney, M.P., Scott, M.G., Baldwin, N., McElnay, J.C., Reduction in the incidence of hospital-acquired MRSA following the introduction of a chlorine dioxide 275ppm based disinfecting agent in a district general hospital (2015) Eur J Hosp Pharm; Wagner, A.K., Soumerai, S.B., Zhang, F., Ross-Degnan, D., Segmented regression analysis of interrupted time series studies in medication use research (2002) J Clin Pharm Ther, 27, pp. 299-309; Jarlier, V., Trystram, D., Brun-Buisson, C., Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program (2010) Arch Intern Med, 170, pp. 552-559

Keywords

antibiotic agent
antibiotic therapy
comorbidity
drug choice
drug use
health care policy
health care quality
health care system
health program
healthcare associated infection
hospital information system
hospital patient
hospital service
human
incidence
length of stay
Letter
methicillin resistant Staphylococcus aureus
methicillin resistant Staphylococcus aureus infection
nonhuman
prescription
program development
quality control procedures
cross infection
disease transmission
drug utilization
hand disinfection
infection control
prevention and control
procedures
Cross Infection
Disease Transmission, Infectious
Drug Utilization
Hand Disinfection
Humans
Infection Control

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jhin.2015.10.016

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958046553&doi=10.1016%2fj.jhin.2015.10.016&partnerID=40&md5=79c46fa0f38414e639f85e6ceccdcc2e

Cite this

@article{17d1058d702e40208bae561e323570cc,

title = "Are we measuring what we intend to measure? Implications for the management of healthcare-acquired infections",

keywords = "antibiotic agent, antibiotic therapy, comorbidity, drug choice, drug use, health care policy, health care quality, health care system, health program, healthcare associated infection, hospital information system, hospital patient, hospital service, human, incidence, length of stay, Letter, methicillin resistant Staphylococcus aureus, methicillin resistant Staphylococcus aureus infection, nonhuman, prescription, program development, quality control procedures, cross infection, disease transmission, drug utilization, hand disinfection, infection control, prevention and control, procedures, Cross Infection, Disease Transmission, Infectious, Drug Utilization, Hand Disinfection, Humans, Infection Control",

author = "M. Aldeyab and M. Scott and G. Conlon-Bingham and A. Nagar and D. Farren and M. Kearney",

note = "Export Date: 15 September 2018 CODEN: JHIND Correspondence Address: Aldeyab, M.; Pharmacy and Medicines Management Centre, Antrim Area Hospital, Northern Health and Social Care Trust, Beech House, United Kingdom; email: Mamoon.Aldeyab@northerntrust.hscni.net References: Aldeyab, M.A., McElnay, J.C., Scott, M.G., A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking (2014) J Antimicrob Chemother, 69, pp. 1132-1141; Peterson, J.C., Paget, S.A., Lachs, M.S., The risk of comorbidity (2012) Ann Rheum Dis, 71, pp. 635-637; Conlon-Bingham, G., Aldeyab, M.A., Kearney, M.P., Scott, M.G., Baldwin, N., McElnay, J.C., Reduction in the incidence of hospital-acquired MRSA following the introduction of a chlorine dioxide 275ppm based disinfecting agent in a district general hospital (2015) Eur J Hosp Pharm; Wagner, A.K., Soumerai, S.B., Zhang, F., Ross-Degnan, D., Segmented regression analysis of interrupted time series studies in medication use research (2002) J Clin Pharm Ther, 27, pp. 299-309; Jarlier, V., Trystram, D., Brun-Buisson, C., Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program (2010) Arch Intern Med, 170, pp. 552-559",

year = "2015",

month = nov,

day = "9",

doi = "10.1016/j.jhin.2015.10.016",

language = "English",

volume = "92",

pages = "206--208",

journal = "Journal of Hospital Infection",

issn = "0195-6701",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Are we measuring what we intend to measure? Implications for the management of healthcare-acquired infections

AU - Aldeyab, M.

AU - Scott, M.

AU - Conlon-Bingham, G.

AU - Nagar, A.

AU - Farren, D.

AU - Kearney, M.

N1 - Export Date: 15 September 2018 CODEN: JHIND Correspondence Address: Aldeyab, M.; Pharmacy and Medicines Management Centre, Antrim Area Hospital, Northern Health and Social Care Trust, Beech House, United Kingdom; email: Mamoon.Aldeyab@northerntrust.hscni.net References: Aldeyab, M.A., McElnay, J.C., Scott, M.G., A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking (2014) J Antimicrob Chemother, 69, pp. 1132-1141; Peterson, J.C., Paget, S.A., Lachs, M.S., The risk of comorbidity (2012) Ann Rheum Dis, 71, pp. 635-637; Conlon-Bingham, G., Aldeyab, M.A., Kearney, M.P., Scott, M.G., Baldwin, N., McElnay, J.C., Reduction in the incidence of hospital-acquired MRSA following the introduction of a chlorine dioxide 275ppm based disinfecting agent in a district general hospital (2015) Eur J Hosp Pharm; Wagner, A.K., Soumerai, S.B., Zhang, F., Ross-Degnan, D., Segmented regression analysis of interrupted time series studies in medication use research (2002) J Clin Pharm Ther, 27, pp. 299-309; Jarlier, V., Trystram, D., Brun-Buisson, C., Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program (2010) Arch Intern Med, 170, pp. 552-559

PY - 2015/11/9

Y1 - 2015/11/9

KW - antibiotic agent

KW - antibiotic therapy

KW - comorbidity

KW - drug choice

KW - drug use

KW - health care policy

KW - health care quality

KW - health care system

KW - health program

KW - healthcare associated infection

KW - hospital information system

KW - hospital patient

KW - hospital service

KW - human

KW - incidence

KW - length of stay

KW - Letter

KW - methicillin resistant Staphylococcus aureus

KW - methicillin resistant Staphylococcus aureus infection

KW - nonhuman

KW - prescription

KW - program development

KW - quality control procedures

KW - cross infection

KW - disease transmission

KW - drug utilization

KW - hand disinfection

KW - infection control

KW - prevention and control

KW - procedures

KW - Cross Infection

KW - Disease Transmission, Infectious

KW - Drug Utilization

KW - Hand Disinfection

KW - Humans

KW - Infection Control

U2 - 10.1016/j.jhin.2015.10.016

DO - 10.1016/j.jhin.2015.10.016

M3 - Letter

VL - 92

SP - 206

EP - 208

JO - Journal of Hospital Infection

JF - Journal of Hospital Infection

SN - 0195-6701

IS - 2

ER -